Clopidogrel Use in <i>CYP2C19</i> Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clopidogrel Use in <i>CYP2C19</i> Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention

Published:2023-05-25 Issue:6 Volume:87 Page:755-763
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Sawayama Yuichi¹,Tomita Yukinori²,Kohyama Soji¹,Higo Yosuke¹,Kodama Kenji¹,Asada Kohei¹,Yagi Noriaki¹,Fukuyama Megumi¹,Hayashi Atsushi¹,Shioyama Wataru¹,Sakai Hiroshi¹,Ozawa Tomoya¹,Isono Tetsuichiro³,Hira Daiki³,Yamamoto Takashi⁴,Morita Shin-ya³,Nakagawa Yoshihisa¹

Affiliation:

1. Department of Cardiovascular Medicine, Shiga University of Medical Science

2. Department of Cardiovascular Medicine, Toyosato Hospital

3. Department of Pharmacy, Shiga University of Medical Science Hospital

4. Department of Cardiovascular Medicine, Kohka Public Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/87/6/87_CJ-22-0826/_pdf

Reference30 articles.

1. 1. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al. Cytochrome P-450 polymorphisms and response to clopidogrel. N Eng J Med 2009; 360: 354–362, doi:10.1056/nejmoa0809171.

2. 2. Wallentin L, James S, Storey RF, Armstrong M, Barratt BJ, Horrow J, et al. Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: A genetic substudy of the PLATO trial. Lancet 2010; 376: 1320–1328, doi:10.1016/s0140-6736(10)61274-3.

3. 3. Ogawa H, Isshiki T, Kimura T, Yokoi H, Nanto S, Takayama M, et al. Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study. J Cardiol 2016; 68: 29–36, doi:10.1016/j.jjcc.2015.07.019.

4. 4. Pereira NL, Rihal C, Lennon R, Marcus G, Shrivastava S, Bell MR, et al. Effect of CYP2C19 genotype on ischemic outcomes during oral P2Y₁₂ inhibitor therapy: A meta-analysis. JACC Cardiovasc Interv 2021; 14: 739–750, doi:10.1016/j.jcin.2021.01.024.

5. 5. Holmes DR Jr, Dehmer GJ, Kaul S, Leifer D, O’Gara PT, Stein CM. ACCF/AHA clopidogrel clinical alert: Approaches to the FDA “boxed warning”: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2010; 56: 321–341, doi:10.1016/j.jacc.2010.05.013.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationships of Proton Pump Inhibitor‐Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study;Clinical Pharmacology & Therapeutics;2024-01-22

2. Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk　― Never Judge a Book by Its Cover ―;Circulation Journal;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3